InSite, Merck Sue Sandoz Over Patent

Xconomy San Francisco — 

InSite Vision, the Alameda, CA-based developer of drugs for eye diseases, said today it has joined pharma giant Merck in bringing a patent infringement lawsuit against Sandoz, a generic drugmaker. Sandoz has recently filed an abbreviated new drug application with the FDA for clearance to start marketing a generic version of azithromycin (Azacite) for the treatment of eye infections. Merck will the take the lead in the patent litigation, Insite said.

By posting a comment, you agree to our terms and conditions.

Comments are closed.